Follow the 현대바이오랜드 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Chemicals sector, 현대바이오랜드 has logged 28 public disclosures. The latest transaction was disclosed on 19 February 2026 (Other). Among the most active insiders: 현대퓨처넷. Every trade is accessible without an account.
28
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.